These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 4780697

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Neuropathic Gaucher's disease with normal 4-methylumbelliferyl-beta-glucosidase activity in the liver.
    Owada M, Sakiyama T, Kitagawa T.
    Pediatr Res; 1977 May; 11(5):641-6. PubMed ID: 870871
    [Abstract] [Full Text] [Related]

  • 23. Glucocerebrosidase: reconstitution of activity from macromolecular components.
    Ho MW, O'Brien JS, Radin NS, Erickson JS.
    Biochem J; 1973 Jan; 131(1):173-6. PubMed ID: 4722035
    [Abstract] [Full Text] [Related]

  • 24. Sulfogalactocerebroside and bis-(monoacylglyceryl)-phosphate as activators of spleen glucocerebrosidase.
    Prence EM, Garrett KO, Panitch H, Basu A, Glew RH, Wherrett JR, Huterer S.
    Clin Chim Acta; 1986 Apr 30; 156(2):179-89. PubMed ID: 3085988
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Sucrose gradient analysis of phospholipid-activated beta-glucosidase in type 1 and type 2 Gaucher's disease.
    Garrett KO, Prence EM, Glew RH.
    Arch Biochem Biophys; 1985 Apr 30; 238(1):344-52. PubMed ID: 3920967
    [Abstract] [Full Text] [Related]

  • 27. Activation of human spleen glucocerebrosidases by monoacylglycol sulfates and diacylglycerol sulfates.
    Gonzales ML, Basu A, de Haas GH, Dijkman R, van Oort MG, Okolo AA, Glew RH.
    Arch Biochem Biophys; 1988 Apr 30; 262(1):345-53. PubMed ID: 3355173
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Brain glucocerebrosidase in Gaucher's disease.
    Daniels LB, Coyle PJ, Glew RH, Radin NS, Labow RS.
    Arch Neurol; 1982 Sep 30; 39(9):550-6. PubMed ID: 6810854
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Relationship between the two immunologically distinguishable forms of glucocerebrosidase in tissue extracts.
    Aerts JM, Donker-Koopman WE, van Laar C, Brul S, Murray GJ, Wenger DA, Barranger JA, Tager JM, Schram AW.
    Eur J Biochem; 1987 Mar 16; 163(3):583-9. PubMed ID: 3830174
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. 2,3-di-O-tetradecyl-1-O-(beta-D-glucopyranosyl)-sn-glycerol is a substrate for human glucocerebrosidase.
    Glew RH, Gopalan V, Hubbell CA, Devraj RV, Lawson RA, Diven WF, Mannock DA.
    Biochem J; 1991 Mar 01; 274 ( Pt 2)(Pt 2):557-63. PubMed ID: 1900989
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Conditions affecting the activity of glucocerebrosidase purified from spleens of control subjects and patients with type 1 Gaucher disease.
    Aerts JM, Sa Miranda MC, Brouwer-Kelder EM, Van Weely S, Barranger JA, Tager JM.
    Biochim Biophys Acta; 1990 Oct 18; 1041(1):55-63. PubMed ID: 2223847
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.